Samsung Group’s biotechnology unit is facing a potential criminal investigation and delisting after South Korea’s financial regulator said that the company “intentionally” violated accounting rules surrounding an initial public offering.
from Accounting Today: Feed https://ift.tt/2OGyYuN
via gqrds
Samsung arm faces criminal probe after breaking accounting rules